Align Technology (ALGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Align Technology's fourth-quarter results are likely to reflect the strength in its Systems & Services business.
Align Technology (ALGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
ALGN is facing a decline in Invisalign ASPs for comprehensive treatment options. This resulted in a decline in the company's revenues.
Two stocks (ALGN and KO) to buy in January trading at least 20% below their average Zacks price targets that also offer great long-term value.
Leerink Partners upgraded Align Technology Inc ALGN, citing upside opportunities throughout 2025 given gross margin expansion opportunities.
Align Technology shares have remained under pressure over the past year due to soft consumer demand for the company's clear aligner products. I expect growth to accelerate to at least 5% in FY25, main
Investors interested in Medical - Dental Supplies stocks are likely familiar with Conmed (CNMD) and Align Technology (ALGN). But which of these two stocks presents investors with the better value oppo
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ i
Here, we discuss five stocks that are likely to generate better than the market, driven by strong demand for existing products and the addition of innovative new devices.
ALGN stock stays on investors' radar, courtesy of its strong Invisalign potential and success with iTero.
SANTA CLARA, Calif.--(BUSINESS WIRE)--Last Wednesday, attorneys from Susman Godfrey LLP and Benesch Friedlander Coplan & Aronoff, LLP filed an antitrust lawsuit on behalf of CDS Litigation, LLC, again
ALGN is facing a decline in Invisalign ASPs for comprehensive treatment options. This results in a decline in the company's revenues.
Investors need to pay close attention to Align Technology (ALGN) stock based on the movements in the options market lately.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE